Earlier this year, a study conducted by the University of Edinburgh found that people who received the COVID-19 vaccine developed by AstraZeneca and the University of Oxford were at a very slightly ...

A: Platelets are part of how our body forms clots to stop bleeding. They are produced in the bone marrow by cells called megakaryocytes, and then enter the blood stream. Normal platelet counts are ...

Please provide your email address to receive an email when new articles are posted on . Individuals with an increased platelet count demonstrated an increased risk for cancer, with the association ...

Since the first report of this test 11 sufficient clinical data have been accumulated to permit a clear delineation of its significance in the classification of diverse types of thrombopenia. Minor ...

A clinical trial of patients undergoing percutaneous coronary intervention (PCI) for acute coronary syndrome (ACS) and stable angina showed that a strategy of rapid genotyping followed by selective ...

LightIntegra Technology, a small company in Vancouver, Canada, that has developed an optical system to improve blood transfusions for cancer patients, has raised $5.3 million in series A venture ...

A routine blood test may pack a bigger punch than previously suspected, suggests a recent analysis of over 3 million Canadian patient records. A finding of thrombocytosis (platelet count >450 x 10 9 ...

Sept. 27, 2004 — Successful eradication of Helicobacter pylori infection results in significant platelet recovery in 56% of patients with chronic idiopathic thrombocytopenic purpura (ITP), according ...

This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they ...